29th Sep 2026 12:48
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:
----------
Incanthera PLC - Manchester, England-based dermatology and oncology technology firm - Pretax loss in year to March 31 widens to GBP2.2 million from GBP2.0 million the year prior. It reports revenue of GBP12,000, against none the year prior. "Since joining Incanthera in June 2026, my focus has been on where this business can deliver success in the future. We have great products, and they are the cornerstone of our new strategy. We are transitioning from a marketing-led, direct-to-consumer business to a focused, partnership-led skincare technology supplier, expanding our global reach through partners who bring scale, established routes to market and access to new customers," CEO Stuart Robertson says.
----------
Wilmington PLC - Birmingham, England-based data, information, education and training for governance, risk and compliance markets - Pretax profit in year to June 30 rises 11% to GBP18.2 million from GBP16.4 million, while revenue improves 34% to GBP120.0 million from GBP89.7 million. "Early Group trading in FY27 has seen a continuation of the momentum built in FY26, and with international macro [governance, risk and compliance] drivers providing a favourable backdrop, we are well positioned for continued growth and on track to achieve market expectations," Chief Executive Officer Mark Milner says. Wilmington lifts its final dividend by 11% to 9.4 pence per share from 8.5p. Its total dividend is raised 8.7% to 12.5p from 11.5p.
----------
Tortilla Mexican Grill PLC - London-based chain of Mexican restaurants - Pretax loss in half-year to June 28 narrows to GBP1.6 million from GBP4.1 million a year prior, ass revenue increases 5.9% to GBP38.5 million from GBP36.3 million. It highlights that system sales hit GBP100.9 million on a 12-month trailing basis, a record high. "This was supported by strong progress made in the UK during the first half, where LFL sales grew by 13.9%, materially outperforming the CGA NIQ RSM Hospitality Business Tracker benchmark which reported that sector LFLs grew only 1.0%," Chief Executive Officer Brandon Stephens says. UK like-for-like sales are up 19% in the 13 weeks to September 27, it adds. In France, sales growth in seven converted Tortilla stores has accelerated, with like-for-like sales up 24% in the same 13-week period. It adds: "While considerable work is still to be done to align the France division's profitability with that of the UK, management is confident that a renewed 'One Tortilla' approach to France coupled with a comprehensive 'levelling-up' programme will drive further sales and margin improvements."
----------
MicroSalt PLC - London-based provider of low-sodium salt products - Pretax loss in six months to June 30 narrows to USD1.4 million from USD1.7 million a year prior, while revenue rises to USD1.4 million from USD835,000. "The first half of 2026 demonstrates the continued strength of our commercial model. Despite the previously reported delay in rollout of the very large snack food order for logistical reasons unrelated to MicroSalt, revenues still increased by 75%; we expanded relationships with existing multinational customers, secured new customers and delivered more than 1.4 billion healthier servings of MicroSalt globally," CEO Rick Guiney says. "We believe MicroSalt is increasingly establishing itself as a commercially proven solution for food manufacturers seeking meaningful sodium reduction without compromising taste, functionality or clean-label requirements. With improving margins, increasing revenue visibility and continued innovation across our product portfolio, we remain confident in our proposition."
----------
Venture Life Group PLC - Berkshire, England-based company that commercialises products for the consumer self-care market, with brands including Balance Activ, Earol and Health & Her - Reports results for 17 months to May 31, and also announces its chief executive officer will step down. Pretax loss in the 17 month period amounts to GBP4.0 million, swinging from profit of GBP19,000 in 2024. Venture Life had changed its year end date from December 31 to "better align with the group's revised strategy". Revenue rises to GBP50.0 million in the 17 months from GBP26.6 million in 2024. "With the business now simplified and focused as a pure play consumer healthcare platform, supported by an agile and talented team, with strong customer and supplier partnerships, we are well placed to capitalise on the opportunities ahead. The board is therefore highly confident in meeting market expectations for the year ending 31 May 2027 and beyond," it adds. Jerry Randall will step down as CEO at the end of 2026. Chief Financial Officer Daniel Wells will succeed him. "The board is progressing the appointment of the CFO successor in accordance with its established succession plans and processes. As part of a long-planned succession and smooth leadership transition, Jerry will remain as a director of the company until 31 May 2027, and after this date will remain as an adviser to the board and senior management team," Venture Life adds.
----------
Genflow Biosciences PLC - London-based biotechnology company specialising in treatments for age-related diseases - Pretax loss in first half of 2026 narrows to GBP420,233 from GBP1.4 million a year prior. Administrative expenses decline to GBP454,311 from GBP2.0 million. Genflow does not generate revenue in either period. The company adds: "Genflow reached a landmark milestone with the successful completion of SLAB, our lead canine healthspan and sarcopenia clinical trial - a significant achievement that validates our SIRT6 centenarian platform in a real-world aging population and strengthens the company's position at the forefront of longevity science. Alongside this milestone, Genflow continued to make strong progress across its programs in both human health and animal health, advancing our mission to extend healthspan through our proprietary SIRT6 centenarian-based gene therapies."
----------
Vulcan Two Group PLC - investment company focused on acquiring e-pharmacy businesses - Pretax loss in six months to June 30 widens to GBP4.1 million from GBP79,892 a year prior. Revenue amounts to GBP10.0 million. It did not report any revenue a year prior. Administrative expenses jump to GBP3.5 million from GBP79,892. "The first half marked Vulcan Two's transformation into an operating ePharmacy Group, bringing three founder-led businesses together onto a single platform. The actions we took, included transferring Webmed's fulfilment to CloudRx and stepping away from lower-margin, higher credit-risk customers. While some of these reduced revenue in the near term, it has left the Group with a higher-quality, more sustainable base. More than 85% of revenues now come from customers who pay at the point of order," Chief Executive Officer Michael Kraftman says. In addition, it announces the Molecule brand launch. It creates a "single identity across the group's consumer, veterinary and professional healthcare channels". It will change its name to Molecule Group PLC, which will be effective "in the coming days".
----------
Time To Act PLC - Stockton-On-Tees, England-based engineering technology for energy transition supply chain - Pretax loss in year to March 31 narrows to GBP420,865 from GBP1.0 million the year prior, while revenue climbs to GBP2.4 million from GBP2.3 million. "As previously stated, I am keen to switch investor focus from looking in the rear-view mirror to the view through our front windscreen. In these audited accounts, the view presented through the front windscreen that we are justifiably pleased with is the unqualified audit opinion with no going concern issues noted for the twelve-month period starting from now," Chief Executive Chris Heminway commented. "I am otherwise pleased to reiterate the continuing positive shift in momentum in the business outlook. Order intake in September (including a few orders drifting into the first few days of October) will be towards the upper end of the communicated GBP1.1 million-1.2 million range, with MTE closing out the best month since its acquisition in May."
----------
Ashington Innovation PLC - special purpose acquisition company - Pretax loss in first half of 2026 narrows to GBP87,211 from GBP117,478. Administrative expenses shrink to GBP80,756 from GBP117,478. Last month, it agreed a GBP160 million reverse takeover of World Metal Group Pte Ltd. WMG is a Singapore-headquartered urban mining platform originally established in 2006. "WMG aligns perfectly with our objective to bring a robust, scalable growth business to London's capital markets and deliver long-term shareholder value," said Ashington Chair Peter Presland.
----------
By Eric Cunha, Alliance News news editor
Comments and questions to [email protected]
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Related Shares:
Ashington InnovTortilla MexicGenflow BiosciVenture LifeMicrosaltTTA.LVulcan TwoWilmingtonINC.L